端粒疾病患者肝脏受累的表现谱
该研究在美国国立卫生研究院连续评估121例已知或疑似端粒疾病患者,其中40例(40%)存在肝脏受累并在本研究中分析,中位随访2.4年;肝脏受累表现包括胆汁淤积型肝酶升高、超声回声增强、肝大及多种组织病理异常。结论认为端粒疾病患者肝脏受累常见且表现多样,对疾病负担和死亡有重要影响。
要点
- 端粒疾病患者中肝脏受累常见,本队列40%(40/121)存在肝脏受累。
- 肝酶升高呈胆汁淤积型,8例(21%)为药物相关肝酶升高。
- 肝脏活检因血小板减少风险而少做,6例活检可见结节性再生性增生、脂肪性肝炎、含铁血黄素沉着、胆汁淤积及肝硬化伴肝脂肪变。
核心结论
- 在端粒疾病患者中,肝脏受累常见并可表现多样,包括肝酶升高以及组织病理学和影像学异常;肝脏疾病对端粒疾病患者的疾病负担和死亡有重要影响。
研究设计与样本
- 在美国国立卫生研究院对121例已知或疑似端粒疾病患者进行连续筛查,其中40例存在肝脏受累并纳入本项研究,中位随访2.4年,收集人口学、实验室、影像学和组织病理学资料。
主要发现
- 40例(占队列40%)存在肝脏受累,中位年龄42岁,肝酶升高呈胆汁淤积型,8例(21%)为药物相关肝酶升高。
- 超声最常见表现为肝回声增强,见于39%(9例)患者,其次为肝大,见于26%(6例)。
- 因血小板减少相关风险,肝脏活检不常进行;6例活检结果不一,可见结节性再生性增生、脂肪性肝炎、含铁血黄素沉着、胆汁淤积及肝硬化伴肝脂肪变。
- 近半数队列存在肺弥散功能异常,25%在随访期间死亡。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Loss-of-function mutations in genes that encode for components of the telomere repair complex cause accelerated telomere shortening. Hepatic involvement has been recognized as a cause of morbidity in telomere diseases, but very few studies have characterized the nature and extent of liver involvement in affected patients. We report the prevalence and characteristics of liver involvement in a large cohort of patients with telomere disease evaluated serially at the National Institutes of Health. One hundred twenty-one patients with known or suspected telomere disease were screened; 40 patients with liver involvement were included in the current study. Median follow-up was 2.4 years. Data were collected regarding their demographic information, laboratory analysis, imaging, and histopathology. Forty patients (40% of the cohort) with a median age of 42 years were found to have liver involvement. Liver enzyme elevation was cholestatic in pattern; 8 (21%) had drug-related enzyme elevations. The most common imaging finding was increased hepatic echogenicity on ultrasound in 39% (9) of patients, followed by hepatomegaly in 26% (6). Biopsies were infrequent because of risk associated with thrombocytopenia, but in 6 patients, there were varying findings: nodular regenerative hyperplasia, steatohepatitis, hemosiderosis, cholestasis, and cirrhosis with hepatic steatosis. Almost half the cohort had pulmonary diffusion abnormalities, and 25% died during the follow-up period. Conclusion: In patients with telomere disease, hepatic involvement is common and can present in diverse ways, including elevated liver enzymes as well as histopathologic and imaging abnormalities. Liver disease has important implications for morbidity and mortality in patients with telomere disease.
引用
- Kapuria D, Ben-Yakov G, Ortolano R, et al. The Spectrum of Hepatic Involvement in Patients With Telomere Disease. Hepatology. 2019. PMID: 30791107. doi:10.1002/hep.30578
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。